• 2021 was a transformative year for Pathway Health, and it is our pleasure to provide a summary of the company’s corporate activity during 2021, including a brief discussion of our plans for 2022. We are pleased to report that we achieved year-over-year patient growth in each of our clinic divisions, with 10% overall growth across […]

  • TORONTO, Jan. 19, 2022 /CNW/ – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) (“Pathway” or the “Company”), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announces the issuance of 75,000 common shares in the capital of the Company (“Common Shares”) to CannTrust Inc. in […]

  • TORONTO, Dec. 17, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) (“Pathway” or the “Company”), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that the Company’s shares have been accepted for listing on the Frankfurt Stock Exchange (“FSE”) and […]

  • Canadian investors are encouraged to watch a BTV feature on Pathway Health on national TV this weekend. BNN Bloomberg – Saturday Dec 18 @ 8:00pm ET, Sunday Dec 19 @ 4:30pm ET During the segment president of Pathway Health, Wayne Cockburn discusses the company’s approach to providing patients with a wide range of interdisciplinary chronic […]

  • Collaboration Agreement on Pathway Health’s Medical Cannabis Management System in Pharmacy to include the Metro Pharmacy and Food Basics Pharmacy banners of Metro Ontario Pharmacies Limited. TORONTO, Dec. 7, 2021 /CNW/ – Pathway Health, Corp. (“Pathway” or the “Company“) (TSXV: PHC) is pleased to announce that it has signed a Collaboration Agreement (the “Agreement”) with Metro Ontario […]

  • TORONTO, Dec. 6, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) (“Pathway” or the “Company”), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has entered into a Letter of Intent (the “LOI”) to acquire the operating assets […]

  • The President of telehealth company, Pathway Health recently joined Steve Darling from Proactive Investors to discuss the company’s recent  news about the company entering into a Service Agreement with Canntab Therapeutics for the oral delivery of cannabinoids in tablet  form.  In the interview, Wayne  Cockburn discussed the reasoning behind signing the agreement with Canntab, how […]

  • TORONTO, Dec. 2, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) (“Pathway” or the “Company”), a leading, integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has engaged Dr. Jimmy Nanda to lead a multi-million dollar expansion of the Company’s allied […]

  • TORONTO, Dec. 2, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) (“Pathway” or the “Company”) is pleased to announce that it has entered into a Service Agreement (the “Agreement”) with Canntab Therapeutics Limited (“PILL”), a Canadian biopharmaceutical company focused on the manufacturing and distribution of a full suite of oral tablet cannabinoid products. “We […]